Journal Logo

Poster Session II: Chronic lymphocytic leukemia and related disorders – Clinical

PS1152 THE USE OF THE BCL-2 INHIBITOR IN CLL PATIENTS WHO PROGRESSED AFTER B-CELL-RECEPTOR INHIBITORS: A RETROSPECTIVE MULTICENTER ITALIAN EXPERIENCE

Innocenti, I.1; Morelli, F.2; Autore, F.1; Piciocchi, A.3; Frustaci, A.4; Mauro, F.R.5; Schiattone, L.6; Trentin, L.7; Poeta, G. Del8; Reda, G.9; Rigolin, G.M.10; Ibatici, A.11; Ciolli, S.12; Coscia, M.13; Sportoletti, P.14; Murru, R.15; Levato, L.16; Gentile, M.17; D’Arena, G.18; Villa, M.R.19; Fontana, R.20; Tedeschi, A.4; Scarfò, L.6; Cuneo, A.10; Foà, R.5; Laurenti, L.1,2

Author Information
doi: 10.1097/01.HS9.0000562892.50367.9f
  • Free

Abstract

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.